Stockscreener 앱 받기
3.80
2.81%
-0.11
시간 외 거래:
3.85
0.05
+1.32%
Mannkind Corp 주식(MNKD)의 최신 뉴스
FDA Approves Mannkind's At-Home Treatment Option for Heart Failure or Kidney Disease - Yahoo Finance
MannKind Corp (MNKD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CT drugmaker raises $50M after FDA approval of new treatment - Hartford Business Journal
H.C. Wainwright reiterates MannKind stock rating on FDA approval By Investing.com - Investing.com South Africa
H.C. Wainwright reiterates MannKind stock rating on FDA approval - Investing.com
MannKind Corp (MNKD) Cash Flow - TradingKey
MannKind Corp (MNKD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
MNKD|MannKind Corp|Price:3.952|Chg%:-0.178 - TradingKey
MannKind Corp (MNKD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
MannKind Corp (MNKD) Institutional Confidence - TradingKey
MannKind Corp (MNKD) Valuation: PE, PB & Fair Value Analysis - TradingKey
MannKind Corp (MNKD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
MNKD Stock Rises Premarket As FDA Verdict Nears – Retail Optimism Builds - Stocktwits
TradingKey - TradingKey
MannKind Corp (MNKD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
MannKind Corp (MNKD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
MNKD Stock Heads For Strongest Month In Over Three Years As FDA Catalyst Draws Closer - Stocktwits
MNKD|MannKind Corp|Price:4.130|Chg%:+0.240 - TradingKey
MannKind (MNKD) Stock Looks Undervalued On Cash Flow Yet Mixed On Broader Checks - Yahoo Finance
MannKind Corporation (MNKD) Shares Surge on FDA Approval and $50M Placement - GuruFocus
MannKind Corporation Raises $50 Million in Private Placement Following FDA Approval of Furoscix ReadyFlow - Kalkine Media
MannKind closes $50M financing, wins FDA nod for Furoscix auto-injector - MassDevice
MannKind Corporation (MNKD) stock price, news, quote and history - Yahoo Finance Singapore
MannKind Announces FDA Approval of Furoscix ReadyFlow, the First and Only Autoinjector Delivering IV-Equivalent Diuretic Therapy for the Treatment of Edema in Adults with Heart Failure or Chronic Kidney Disease - FinanzNachrichten.de
MNKD Stock Rises 8% On Furoscix ReadyFlow Approval And $50M Funding Boost - Yahoo Finance
MannKind Stock Jumps After FDA Clears Furoscix Auto-Injector, Firm Secures $50 Million PIPE - finance.biggo.com
MannKind Corporation (MNKD) Stock Price, News, Quote & History - Yahoo! Finance Canada
MannKind Wins FDA Approval for Furoscix ReadyFlow, Secures $50M PIPE - Yahoo Finance
FDA Approves Furosemide Autoinjector for Treatment of Edema in CKD or Heart Failure - Pharmacy Times
H.C. Wainwright reiterates Buy on MannKind stock ahead of PDUFA - Investing.com
MannKind shares surge after FDA approves Furoscix ReadyFlow and company secures $50 million financing - Yahoo Finance
H.C. Wainwright reiterates Buy on MannKind stock ahead of PDUFA By Investing.com - Investing.com Canada
Why is MannKind stock rallying today? - Investing.com
MannKind raises $50 million in private placement led by Frazier - Investing.com
MannKind stock jumps 6% on FDA approval, $50M financing - Investing.com
MannKind Announces $50 Million Private Placement - Yahoo Finance
At-home autoinjector delivers IV-equivalent therapy in under 10 seconds - Stock Titan
MannKind wins FDA approval for Furoscix ReadyFlow autoinjector to treat edema in adults with heart failure or CKD - Bitget
MannKind (MNKD) Set for Potential Growth Ahead of FDA Decision - GuruFocus
MNKD Stock Jumps On Receiving FDA Approval For Afrezza To Treat Diabetes In Children - Stocktwits
Form 4 MannKind Corp For: 21 July By Investing.com - Investing.com South Africa
MannKind Stock Plummets After Partner United Therapeutics Unveils New ‘Category Killer Product’ - Stocktwits
MannKind EVP David Thomson sells $97,641 in MNKD shares on July 17 By Investing.com - Investing.com South Africa
MannKind EVP David Thomson sells $97,641 in MNKD shares on July 17 - Investing.com India
Form 4 MannKind Corp For: 21 July - Investing.com India
MNKD Stock Price, Quote & Chart - ChartMill
MannKind Executive Sells 123,000 Shares Amid Performance Concerns - Intellectia AI
1.84%
0.91%
자본화:
|
볼륨(24시간):